At the beginning of the last century, Rusznyak and Szent-Gyorgyi reported that citrus fruits contain diverse substances other than vitamin C, which can prevent capillary fragility. These substances were the polyphenols (flavonoids, phenolic acids, lignans, coumarins) or flavonoids contained in large quantities in fruit, vegetables, cereals, and beverages, and which may have a positive effect under conditions of stress and other neurological dysfunctions \[[@cit0001]\]. Constituents of grapes, such as quercetin, resveratrol, kaempferol, catechin, epicatechin and anthocyanins, constitute more than 70% of the grape polyphenols. Natural compounds have long been recognized to possess anti-inflammatory, antioxidant, antiallergic, hepatoprotective, antithrombotic, antiviral and anticancer activities.

Flavonoids, previously called vitamin P or vitamin C2, are numerous; in fact, to date, about 800 different flavonoids have been isolated. Flavonoids are polyphenolic secondary metabolites classified into anthocyanins, flavonols, flavones, flavan-3-ols, flavanones, isoflavones, and chalcones; they are ubiquitous in food and potentiate the anti-scorbutic activity shown in a number of animal studies. Flavonoids cannot be considered vitamins, since they produce pharmacologic effects rather than nutritional ones. It is well known that polyphenols such as coumarin, curcumin, catechin, resveratrol, anthocyanidin, tannin, rutin, isoflavone, quercetin, etc. exert antioxidant properties, and these are found in red wine, chocolate, tea, pomegranate and fruit juices, where they are the greatest contributors of flavonoids in the human diet along with vegetables \[[@cit0002]\]. The hydroxyl groups of these polyphenols enable them to form glycosidic linkages with sugars. Most polyphenols occur naturally as glycosides which are hydrolyzed and converted into their respective aglycones by lactase phlorizin hydrolases on the cell surface as well as cellular and bacterial, prior to absorption by glycosidases of the intestinal flora \[[@cit0003]\].

Found in plants, polyphenols, which are colored phenolic substances, comprise the major sources of red, blue and yellow pigments which exhibit pleiotropic biological activities such as tissue protection, reduced capillary fragility and/or permeability, antioxidant protecting effects and chelating properties such as the ability to chelate divalent metal cations (e.g., Cu^++^, Fe^++^). Their antioxidant functions are exerted by removing the catalysts of lipid peroxidation reactions, aldose reductase, phosphodiesterases, and o-methyltransferase \[[@cit0004]\]. However, no clinical diseases associated with polyphenol deprivation have been reported.

The large number of flavonoids leads to many different mechanisms of action and often they are tested in clinical trials \[[@cit0005]\]. They have neurological effect and therefore are used as antidepressants \[[@cit0006]\]. Some flavonoids exert an antidepressant effect by elevating glucocorticoid receptors, serotonin norepinephrine and/or brain-derived neurotrophic factor, modulating the hypothalamus-pituitary-adrenal axis \[[@cit0007]\].

It has been reported that certain natural flavonoids have anti-inflammatory activities, used for neuropsychiatric disorders \[[@cit0008]\]. Their intake is associated with decreased incidence of dementia and improvement of cognitive dysfunctions \[[@cit0009]\].

There is reason to believe that oxygen radicals are involved in the pathophysiology of inflammatory cells which generate and release reactive oxygen species. The antioxidative properties of polyphenols are considered to benefit human health, and the antioxidant flavonoid quercetin prevents oxidative stress and leads to its reduction \[[@cit0010]\]. The antioxidant polyphenols can turn off the reactive oxygen species (ROS) activity and prevent cellular tissue damage by reacting with oxidizing free radicals \[[@cit0011]\], and therefore can be used for therapies in diverse pathologies such as autoimmune diseases, inflammatory disorders and cancer \[[@cit0012]\]. However, whether polyphenols alter biological effects during their therapeutic and preventive actions remains unclear. It has been reported that polyphenols may alleviate the adverse effects of chemotherapy and radiotherapy, but may antagonize antitumor effects by reducing oxidative damage \[[@cit0013]\].

Whether polyphenols can antagonize antitumor effects of radiotherapy and chemotherapy remains unclear \[[@cit0012]\]. They may modulate gene expression influencing cellular proliferation and differentiation \[[@cit0014]\]. Moreover, it may cause the modulation of the intracellular kinase pathways p38, mitogen-activated protein kinase (MAPK), and extracellular regulated kinase (ERK). Polyphenols may downregulate inflammatory responses in LPS-activated murine peritoneal macrophages, suppressing NFκB and MAPK signaling pathways \[[@cit0015]\].

The Janus kinase activation (JAK)-STAT pathway is an important signal transduction pathway for numerous cytokines and chemokines, which binds its receptor and leads to JAK activation and phosphorylates STATs \[[@cit0016]\]. Since the JAK-STAT pathway plays a crucial role in dysregulation of the T-cell response and is involved in inflammatory and allergic diseases, it is likely that these signals are influenced by polyphenols.

**Mast cells** ([Fig. 1](#f0001){ref-type="fig"}) derive from a distinct precursor in the bone marrow and are multifunctional immune cells implicated in the pathogenesis of inflammatory disease allergy, autoimmunity and cancer \[[@cit0017]\]. Crosslinking of FcεRI with antigen or IgE induces Lyn activation, which phosphorylates the immunoreceptor tyrosine-based activation motif (ITAM). ITAM-γ chain recruits spleen tyrosine kinase (Syk) to the receptor. This phosphorylation activates phospholipase C gamma (PLC-γ), leading to the stimulation of inositol 1,4,5-triphosphate (IP3), which regulates the calcium (Ca^2+^) flux and diacylglycerol (DAG), which acts on PKC activity. Therefore, in MCs, these signal pathways and others can cause immediate degranulation and/or the late generation of arachidonic acid products, cytokines and chemokines. Mast cells can perform important beneficial roles in host defense, and they can secrete mediators without overt degranulation \[[@cit0018]\]. Human mast cells contain and release several inflammatory compounds and are essential for allergies, innate and acquired immunity, and inflammation \[[@cit0019]\]. They mediate all these processes through the release of various mediators: histamine, tryptase (α and β), chymase, proteoglycans, prostaglandin D2, and produce leukotrienes, whose receptors are expressed on rat microglia \[[@cit0020]\]. Tryptase activates protease-activated receptors (PARs), which are G-protein-coupled receptors, and participate in allergic diseases and inflammatory reactions mediated by human mast cells \[[@cit0021]\]. Increased secretion of mast cell tryptase in certain disorders, such as bronchial asthma, may augment neurogenic inflammation \[[@cit0022]\].
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Under stress, activated mast cells, which have been proposed as an immune gate to the brain, as well as environmental sensors, generate cytokines/chemokines which together with neuropeptides are involved in the development of several neuropathological processes, and are implicated in inflammation of the central nervous system \[[@cit0023]\]. The release of neuropeptides from sensory nerves causes an increase in vascular permeability, plasma extravasation and edema \[[@cit0024]\]. Mast cells are stimulated and activated by cytokines, growth factors, hormones, and bacterial and viral compounds, leading to differential release of distinct mediators without degranulation. These effects appear to involve *de novo* synthesis of mediators, such as vascular endothelial growth factor and interleukin (IL)-6 \[[@cit0025]\].

Interleukin 6 is a pleiotropic cytokine produced by Th2 cells or mast cell activation. IL-6 mediates various pathophysiological processes, such as immune responses, inflammation, acute phase responses, haematopoiesis, and acute stress, through activation of the hypothalamicpituitary-adrenal axis \[[@cit0026]\]. IL-6 is important for mast cell maturation and proliferation. This cytokine has been shown to exacerbate several neurological dysfunctions induced or mediated by other cytokines \[[@cit0027]\]. Mast cells can accumulate in inflammatory tissues in response to a specific C-C chemokine, such as regulated on activation, normal T-cell expressed and secreted (RANTES) and MCP-1. Injections of hrRANTES or monocyte chemoattractant protein-1 (MCP-1) in skin tissue provided direct *in vivo* evidence that RANTES has a significant effect on mast cell recruitment and histidine decarboxylase (HDC) mRNA generation \[[@cit0028]\]. HDC is an important mast cell biochemical and functional marker for the generation of histamine from histidine. Histamine is expressed by neurons involved in many brain functions \[[@cit0029]\]. The activity of the HDC enzyme is altered in various neurological diseases \[[@cit0030]\]. The flavonoid quercetin has a variety of functions including anti-allergic and neuroprotective activities, and it is known to inhibit histamine release from human basophils and murine mast cells \[[@cit0031]\]. Cloning the HDC cDNA probe into the p-Mal plasmid and using it for Northern blot hybridization, we previously showed that quercetin has an inhibitory effect on HDC mRNA, and tryptase and IL-6 release by the human mast cell line HMC-1 \[[@cit0027]\]. The suppression of HDC mRNA transcription and tryptase and IL-6 production by quercetin on mast cells may clarify in part many pathological conditions associated with several inflammatory disorders, including neurological diseases and allergies \[[@cit0032]\].

**Quercetin** (3,3',4',5,7-pentahydroxyflavone) is a ubiquitous flavonoid contained in vegetables and fruits and is one of the most widely popular flavonoids ingested in food by humans \[[@cit0033]\]. After quercetin ingestion through vegetables and/or fruits, quercetin glycosides are metabolized, absorbed, and circulated in the blood. Subsequently, after conjugation, it is transported and modified in the liver before re-entering the circulation to be transported to other tissues, such as brain and muscles. Like other polyphenols, quercetin exerts anti-cancer activities, and has anti-oxidative and anti-inflammatory properties. Quercetin promotes nitric oxide production via the reduction of dietary nitrite in the stomach, and likely the circulation \[[@cit0034]\]. The strong reducing power of quercetin causes a reduction in the availability of nitrite that influences vascular function \[[@cit0034]\]. Quercetin has a negative effect on intracellular regulatory signaling events initiated by FcεRI cross-linking and other activating receptors on mast cells \[[@cit0035]\]. Quercetin may exert physiological functions though the interaction with phosphatidylinositol-3-phosphate kinase (PI3K), mitogen-activated protein kinase (MAPK), extracellular signal regulated kinase (ERK), kinase (MEK) 1, and others \[[@cit0036]\]. Quercetin may also inhibit PI3K enzymatic activity by displacing ATP binding from PI3K and activate AMP-activated protein kinase (AMPK), which exert anticancer and antiinflammatory effects \[[@cit0037]\]. Therefore, besides possessing antioxidative properties, quercetin and its related polyphenols activate in the cells several biological functions which help organs, such as brain blood vessels, intestine and muscle, to work better \[[@cit0038]\]. Therefore, quercetin is an anti-oxidant polyphenol with potent anticarcinogenic and anti-inflammatory activity. As an anti-inflammatory, quercetin has the capacity to influence arachidonic cascade products such as inhibition of prostaglandin E2 and LTB4 in acute inflammation induced by carrageenan in rodents \[[@cit0039]\]. Quercetin also exerts its anti-inflammatory properties by inhibiting mast cell degranulation and therefore all the pro-inflammatory compounds contained in granules, including tumor necrosis factor (TNF) \[[@cit0022]\].

Clinical studies indicate that quercetin and other flavonoids have cytoprotective activity, and when they are used together with other treatment modalities, flavonoids are useful for the treatment of acute and chronic inflammatory conditions such as asthma \[[@cit0040]\].

The major metabolite of quercetin is quercetin-3-O-β-D-glucuronide, which exerts beneficial activity when distributed in the tissues and contributes to the activation of many physiological functions \[[@cit0037]\].

Quercetin has some effects in many organs including brain, blood vessels, muscle, intestine, liver, kidney, skin and bone, and influences neurodegenerative diseases, mood disorders, atherosclerosis, and metabolic syndrome, where mast cells are likely involved \[[@cit0037]\]. In addition, quercetin treatments of neurodegenerative diseases cause modulation of pro-inflammatory and anti-inflammatory cytokines and chemokines \[[@cit0041]\].

The flavonoid quercetin has a variety of functions including the inhibition of histamine release from human basophils and murine mast cells \[[@cit0042]\]. Moreover, quercetin is a potent anti-cytokine and chemokine generated from several cell types, which has an inhibitor effect in immunological and non-immunological conditions, mediated by mast cells \[[@cit0043]\]. It has been reported that quercetin inhibits, in a dose-response manner, tryptase and MCP-1 \[[@cit0027]\]. In addition, using RT-PCR, quercetin inhibits the transcription of histidine decarboxylase, the enzyme responsible for the generation of histamine from histidine. These data suggest that quercetin is a good candidate for reducing the release of pro-inflammatory mast cell mediators \[[@cit0027]\]. Quercetin inhibits contact dermatitis and photosensitivity in humans and suppresses ultraviolet irradiation-induced expression of inflammatory cytokines IL-1β, IL-6, IL-8 and TNF in human keratinocytes \[[@cit0031]\].

**Luteolin (**3',4',5,7-tetrahydroxyflavone) is a flavone, a natural compound, with anti-oxidant properties and the capacity to inhibit proliferation of some cancer cells, with a mediator effect on mast cell-mediated allergy, and inflammatory and autoimmune disorders \[[@cit0044]\]. Luteolin is found in tea, olive fruit extract, vegetables and fruits, and is well tolerated and safe in children treated for autism spectrum disorders (ASD), demonstrating that it has neuroprotective activity \[[@cit0044]\]. Luteolin belongs to a flavone group of compounds (flavonoids), possesses anti-oxidant properties, inhibits proliferation of some cancer cells and exerts a regulatory effect on mast cell-mediated inflammatory diseases and allergy \[[@cit0045]\]. Moreover, luteolin inhibits T-cell activation, acute and chronic inflammation, and immune cells in patients affected by multiple sclerosis, reduces cognitive decline in rats and increases spatial memory in mice \[[@cit0046]\].

Recently, Theoharides *et al*. showed that luteolin treatment of activated human cultured keratinocytes *in vitro* inhibits their proliferation and suppresses TNF-induced production of inflammatory mediators IL-6, IL-8 and vascular endothelial growth factor (VEGF) \[[@cit0047]\]. In addition, they showed that luteolin decreases TNF-triggered activation of the transcription factor NF-κB at both protein and gene transcription levels. These authors demonstrated that luteolin is a promising candidate for development into effective treatment for chronic inflammatory disorders.

Furthermore, other authors reported that luteolin has the capacity to arrest the cell cycle during the G1 phase in several forms of cancer cell proliferations *in vivo* and *in vitro* \[[@cit0048]\]. Luteolin is a strong activator of apoptosis with an unclear mechanism \[[@cit0049]\]. In several carcinomas, luteolin enhances the expression of Fas through triggering the degradation of signal transducer and activator of transcription 3 (STAT3) \[[@cit0050]\]. The biological activity of luteolin formula is due to the hydroxyl moieties and the 2-3 double bond. The intake of luteolin is inversely associated with subsequent coronary heart disease in some but not all prospective epidemiological studies \[[@cit0051]\]*.*

The release of IL-1, IL-6 and TNF (inflammatory cytokines) after stimulation might lead to the recruitment of T cells and mast cells in the inflamed tissue and the generation of chemokines such as IL-8, an α-chemokine (CXC chemokine), and/or MCP-1, a β-chemokine (CC chemokine) \[[@cit0026]\]. TNF has been shown to induce IL-8 (CXCL8) mRNA expression in a melanoma cell line and upregulate IL-8 receptor expression in normal melanocytes. IL-8 is a chemokine important in inflammatory skin diseases, and is produced by monocytes, mast cells, fibroblasts, endothelial cells, dendritic cells and keratinocytes. IL-8 is chemotactic to neutrophils, T-lymphocytes, basophils and keratinocytes, and its gene expression is significantly increased in skin diseases, an effect inhibited by luteolin \[[@cit0052]-[@cit0056]\].

However, more studies on the therapeutic and neuroprotective effects of polyphenols are needed, and their precise mechanism of action still remains to be clarified.
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